Methylprednisolone Recruiting Phase 3 Trials for Lymphohistiocytosis, Hemophagocytic Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04077905Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis.
NCT02631109L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis
NCT02912702L-DEP as an Initial Treatment for EBV-HLH